Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
Abstract Ovarian cancer remains the most fatal gynecologic malignancy worldwide due to delayed diagnosis as well as recurrence and drug resistance. Thus, the development of new tumor-related molecules with high sensitivity and specificity to replace or supplement existing tools is urgently needed. C...
Saved in:
Main Authors: | Kaipeng Xie (Author), Chenyang Fu (Author), Suli Wang (Author), Hanzi Xu (Author), Siyu Liu (Author), Yang Shao (Author), Zhen Gong (Author), Xiaoli Wu (Author), Bo Xu (Author), Jing Han (Author), Juan Xu (Author), Pengfei Xu (Author), Xuemei Jia (Author), Jiangping Wu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer
by: Lili Ge, et al.
Published: (2022) -
Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer
by: Madhumita Chatterjee, et al.
Published: (2017) -
A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies
by: Lin Cheng, et al.
Published: (2017) -
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
by: Xuyao Xu, et al.
Published: (2023) -
Platelet protein biomarker panel for ovarian cancer diagnosis
by: Marta Lomnytska, et al.
Published: (2018)